Johnson & Johnson

(NYSE: JNJ)
Healthcare  |  Drug Manufacturers—General
134.47 -4.505 -3.24%
Stock Price | Feb. 28, 2020, 3:59 p.m.
0 Followers
Bid: 134.22
Ask: 135.5
Prev. Close: 138.97
52 Week Low: 126.1
52 Week High: 154.5
PE Ratio: 24.71048
Dividend Yield: 273.0%

Company Summary

Johnson & Johnson is the world's largest and most diverse healthcare company. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. Geographically, just over half of total revenue is generated in the United States.

Read more Read less

Recently Viewed Tickers

Free JNJ Testing Key Resistance

1 month ago

Premium 05/21/2015 Recap - Members only

4 years ago

Free Preparing for the Week of May 11

4 years ago

Premium Trade Idea Johnson & Johnson (JNJ) - Update

5 years ago

Premium Johnson & Johnson (JNJ) Trade Scenarios - Video

5 years ago

Free S&P500 - back up the truck buy signal forming!

2 Comments
5 years ago